← Back
Data updated: Jul 17, 2026
SCHERER LABS
Generics Pharmaceuticals
SCHERER LABS is a generic drug manufacturer with 6 FDA-approved products.
1977
Since
6
Drugs
-
Trials
0
New Drugs (2yr)
SCHERER LABS's Key Drugs
SCHERER LABS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
SCHERER LABS's Recent FDA Approvals
New NDA/BLA approvals for SCHERER LABS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
SCHERER LABS's Therapeutic Areas
Disease areas where SCHERER LABS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
SCHERER LABS Pipeline Snapshot
Active clinical trials for SCHERER LABS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1977-02-01
- Latest
- 1978-05-10
- Applications
- 6